This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
5 Trendy Earnings Charts to Watch
by Tracey Ryniec
It's not all about tech companies. These 5 are in hot industries and have intriguing earnings charts.
Carlisle (CSL) Q2 Earnings & Revenues Surpass Estimates
by Zacks Equity Research
Carlisle's (CSL) Q2 revenues decline 22.1% year over year, owing to lackluster performance across all of its segments on a decline in sales volume due to the coronavirus outbreak-led issues.
Cintas (CTAS) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Cintas' (CTAS) fiscal Q4 performance is expected to have gained from an expanded product portfolio and the G&K Services buyout despite the pandemic-led market downturn.
The Zacks Analyst Blog Highlights: Graphic Packaging, Dover, Cintas, Allegion and Reliance Steel & Aluminum
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Graphic Packaging, Dover, Cintas, Allegion and Reliance Steel & Aluminum
Donaldson (DCI) Displays Bright Prospects Amid Headwinds
by Zacks Equity Research
Donaldson (DCI) is likely to gain from solid product portfolio, supply-chain optimization, growing e-commerce business and growth investments. The pandemic-led issues and high debt are concerning.
Grainger (GWW) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Grainger's (GWW) second-quarter results are likely to reflect coronavirus-induced demand for certain products and e-commerce sales, offset by lower demand in manufacturing and transportation industries.
Buy 5 Industrial Product Stocks Ahead of Q2 Earnings Next Week
by Nalak Das
A handful of industrial product developers with a favorable Zacks Rank are poised to beat earnings estimates next week.
Cintas (CTAS) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
by Zacks Equity Research
Cintas (CTAS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cintas' (CTAS) First Aid & Safety Segment Launches ZOLL AED 3
by Zacks Equity Research
Cintas (CTAS) is likely to gain from solid product offerings and innovation abilities. It recently launches ZOLL AED 3, enabling rescuers to quickly provide effective treatment to cardiac emergencies.
Why Cintas (CTAS) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Cintas (CTAS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
A New Strategist Game: Global Week Ahead
by John Blank
A swift global coronavirus pandemic opened up a new, nimble stock strategist game. How low can S&P 500 earnings go, and how cloudy can the outlook become?
Cintas (CTAS) Q3 Earnings & Revenues Beat Estimates, Up Y/Y
by Zacks Equity Research
Cintas' (CTAS) third-quarter fiscal 2020 earnings and revenues increase year over year due to strong performance in its segmental businesses.
The Market's Worst Days are Behind Us
by Sheraz Mian
With the S&P 500 index historically losing about a third of its value in response to recessions, it is reasonable to expect that the bulk of the pullback is behind us at this stage...
Cintas (CTAS) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Cintas (CTAS) delivered earnings and revenue surprises of 6.93% and 0.79%, respectively, for the quarter ended February 2020. Do the numbers hold clues to what lies ahead for the stock?
Reasons to Hold Crown Holdings Stock in Your Portfolio Now
by Zacks Equity Research
The growing popularity of beverage can as a preferred package for marketers and consumers globally bodes well for Crown Holdings (CCK).
John Bean Bets on Strategic Initiatives Amid Low Orders
by Zacks Equity Research
John Bean Technologies (JBT) is progressing well on its Elevate plan and acquisitions strategy. However, low order rates in the FoodTech segment and coronavirus impact clouds near term outlook.
Here's Why You Should Hold on to O-I Glass Stock for Now
by Zacks Equity Research
Given its focus on innovation, capacity expansions and acquisitions, O-I Glass (OI) is worth retaining in the portfolio at the moment.
Cintas (CTAS) to Report Q3 Results: Wall Street Expects Earnings Growth
by Zacks Equity Research
Cintas (CTAS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nordson's (NDSN) Q1 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Nordson's (NDSN) first-quarter fiscal 2020 earnings decline year over year on account of fall in sales.
Emerson (EMR) Discusses Strategic Targets at Investor Day
by Zacks Equity Research
Emerson (EMR) expects digital transformation, investments, productivity and cost reduction efforts to deliver high values to customers and shareholders.
Reasons to Hold Avery Dennison Stock in Your Portfolio Now
by Zacks Equity Research
Given its focus on pricing action, restructuring activities and stellar growth projections, Avery Dennison (AVY) stock is worth retaining in the portfolio at the moment.
Ball Corp Strong on Solid Beverage-Can Demand Amid FX Woes
by Zacks Equity Research
Ball Corp (BLL) poised to capitalize on increasing beverage-can demand by investing in capacity and products.
Moody's (MCO) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Moody's (MCO) delivered earnings and revenue surprises of 4.17% and 1.75%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
IQVIA Holdings (IQV) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
IQVIA (IQV) delivered earnings and revenue surprises of 1.16% and 1.87%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
CME Group (CME) Lags Q4 Earnings and Revenue Estimates
by Zacks Equity Research
CME (CME) delivered earnings and revenue surprises of -1.30% and -0.74%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?